The following updates have been posted to the CMS/Medicare website.
MM5923 – Additional Clarification to Chapter 17, Section 40, Regarding Processing of Drug Claims with the JW Modifier
http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5923.pdf
MM5913 – New Waived Tests
http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5913.pdf
Revised:
MM5655 – Clarification on Billing for the Oral Three Drug Combination Anti-Emetic (Aprepitant)
http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5655.pdf
MM5818 – Erythropoiesis Stimulating Agents (ESAs) in Cancer and Related Neoplastic Conditions
http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5818.pdf
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment